Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
4
80%
Ph phase_1
1
20%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
4(80.0%)
Phase 1Safety & dosage
1(20.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(4)
Completed(1)

Detailed Status

Active, not recruiting2
Not yet recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 14 (80.0%)
Phase 11 (20.0%)

Trials by Status

completed120%
active_not_recruiting240%
not_yet_recruiting240%

Recent Activity

2 active trials
Showing 5 of 5
not_yet_recruitingphase_1

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

NCT07297667
active_not_recruitingearly_phase_1

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)

NCT06789081
not_yet_recruitingearly_phase_1

A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma

NCT07104682
completedearly_phase_1

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma

NCT06827886
active_not_recruitingearly_phase_1

CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma

NCT06813417

Clinical Trials (5)

Showing 5 of 5 trials
NCT07297667Phase 1

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Not Yet Recruiting
NCT06789081Early Phase 1

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma (CLIC-YYC-GPNMB-02)

Active Not Recruiting
NCT07104682Early Phase 1

A Study to Determine the Safety and Effectiveness of the Investigational Cellular Therapy GCAR1 in a Patient With Alveolar Soft Part Sarcoma

Not Yet Recruiting
NCT06827886Early Phase 1

GPNMB-targeting Chimeric Antigen Receptor T-Cell Therapy (GCAR1) for a Patient With Alveolar Soft Part Sarcoma

Completed
NCT06813417Early Phase 1

CAR T Therapy With GCAR1 for Relapsed Alveolar Soft Part Sarcoma

Active Not Recruiting

All 5 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
5